Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nilotinib in Relapsed or Metastatic PVNS/TGCT/dtGCT
NCT01207492Phase 2Completed
- Sponsor
- Andrew J. Wagner
- Start
- Sep 2010
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nilotinib in pigmented villonodular synovitis (PVNS), diffuse-type tenosynovial giant cell tumor (D-TSGCT), tenosynovial giant cell tumor (TGCT), sponsored by Andrew J. Wagner. Started Sep 2010; status: completed.
02
Drugs
nilotinib
03
Conditions
pigmented villonodular synovitis (PVNS)diffuse-type tenosynovial giant cell tumor (D-TSGCT)tenosynovial giant cell tumor (TGCT)
Beyond the preview
Go deeper on NCT01207492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01207492.